Shares of Granules India shed nearly 3% intraday on August 22 after the company received 2 observations from USFDA. United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Virginia, USA on August 21, with two minor observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.
Get a Free Trial from Dollar Advisory
Visit: www.dollaradvisory.com
Call Us: 9111179961
No comments:
Post a Comment